Objective: To examine in humans the effects on serum lipids, lipoproteins and fat-soluble antioxidants of a daily consumption of 2.5 g plant stanols, consumed either once per day at lunch or divided over the three meals. Design: A randomized, double-blind, placebo-controlled, cross-over design. Subjects: Thirty-nine healthy normocholesterolemic or mildly hypercholesterolemic subjects participated. Interventions: Each subject consumed in random order; no plant stanols; 2.5 g plant stanols at lunch; and 2.5 g plant stanols divided over the three meals (0.42 g at breakfast, 0.84 g at lunch and 1.25 g at dinner, which is proportional to dietary cholesterol intake). Each period lasted 4 weeks. Plant stanols were esteri®ed with fatty acids from low erucic rapeseed oil (LEAR) and incorporated into margarines or shortenings. Results: Consumption of 2.5 g plant stanols at lunch results in a similar low-density lipoprotein (LDL)-cholesterol-lowering ef®cacy compared to consumption of 2.5 g plant stanols divided over the three meals (À0.29 mmolal compared with the control period (P`0.001; 95% CI, À0.19 to À0.39 mmolal) for the once per day diet and À0.31 mmolal (P`0.001; 95% CI, À0.20 to À0.41 mmolal)) for the three times per day period). High-density Lipoprotein (HDL) cholesterol and triacylglycerol concentrations did not change. After standardization for LDL cholesterol, the sum of the most lipophylic hydrocarbon carotenoids (ie a-carotene, b-carotene and lycopene) in particular was slightly, though not signi®cantly, lowered by À0.017 + 0.018 mmolammol LDL cholesterol (P 0.307) after the once per day period and by À0.032 + 0.016 mmolammol LDL cholesterol (P 0.049) after the three times per day period. Conclusions: Our ®ndings suggest that for lowering LDL cholesterol concentrations it is not necessary to consume products rich in plant stanol ester at each meal or simultaneously with dietary cholesterol.
Introduction
Plant stanols are useful hypocholesterolemic agents since a daily intake of 2 ± 3 g lowers LDL cholesterol concentrations by 10 ± 15% as found in various populations (Wester, 1999; Law, 2000) . The proposed mechanism is that plant stanols reduce the micellar solubility of cholesterol and consequently lower intestinal absorption of both exogenous and endogenous cholesterol (Heinemann et al, 1991) . This suggests that plant stanol esters should be consumed at each meal to obtain a maximal cholesterol-lowering effect. However, consuming plant stanol esters at lunch and dinner only (Weststrate & Meijer, 1998) showed a decrease in LDL cholesterol comparable to that when consumed three times daily (Miettinen et al, 1995; Plat & Mensink, 2000) . This suggests that plant stanols are active in the intestinal tract for at least a few hours. It has, however, never systematically been evaluated whether the ef®cacy of plant stanols to lower serum LDL cholesterol depends on consumption frequency.
The main purpose of the present study therefore was to examine in a normocholesterolemic and mildly hypercholesterolemic population the effects on serum lipids and lipoproteins of a margarine and shortening enriched with plant stanol esters, consumed three times per day, vs an equal dose of plant stanol esters, consumed once per day. Also effects on plasma fat soluble antioxidant concentrations were evaluated, as these may be affected by consumption of plant sterol and stanol esters (Weststrate & Meijer, 1998; Gylling & Miettinen, 1999) .
Methods

Subjects
Forty-three subjects from Maastricht and surrounding areas applied for the study. Twenty-six of these volunteers had participated in a previous study on the effects of plant stanol esters on serum lipids and lipoproteins (Plat & Mensink, 2000) , while the others were recruited via posters in public buildings. Subjects were invited for a screening visit to see if they met our eligibility criteria: age 18 ± 65 y, fasting serum total cholesterol concentration`6.5 mmolal (251 mgadl), fasting serum triacylglycerol concentratioǹ 3.0 mmolal), body mass index`30 kgam 2 , diastolic blood pressure`95 mmHg, systolic blood pressure`160 mmHg, no presence of proteinuria or glucosuria, no use of medication or a diet known to affect serum lipids, and no history of coronary heart disease. Volunteers had not donated blood at least 4 weeks before or during this trial, and did not participate in another biomedical study. All subjects gave their written informed consent before the start of the study. A population of normocholesterolemic and mildly hypercholesterolemic subjects was used, since the serum cholesterol lowering ef®cacy of plant stanol esters Ð expressed as a percentage Ð does not depend on initial serum LDL cholesterol concentrations (Wester, 1999; Law, 2000) . Hypercholesterolemic subjects were not included, as many of these patients have a history of cardiovascular disease, or use medication or a diet known to affect serum lipids, which were all exclusion criteria.
One subject was excluded for a serum total cholesterol concentration b6.5 mmolal and two subjects decided not to participate. Consequently, the study started with 40 volunteers. One subject dropped out during the ®rst week, because she could not combine the study protocol with her lifestyle. The remaining 39 volunteers, 28 women and 11 men, completed the study successfully. These participants were 31 + 14 y of age (mean + s.d.) and had a body mass index of 22.7 + 2.6 kgam 2 . Before the study started, mean serum total cholesterol and triacylglycerol concentrations were 4.74 + 0.85 mmolal (range 2.83 ± 6.28 mmolal) and 0.99 + 0.39 mmolal (range 0.39 ± 1.84 mmolal) in women and 4.94 + 89 mmolal (range 3.37 ± 6.15 mmolal) and 0.97 + 0.53 mmolal (range 0.44 ± 2.02 mmolal) in men. Seventeen women had cholesterol concentrations below 5.0 mmolal (normocholesterolemic) and 11 women had cholesterol concentrations between 5.0 and 6.5 mmolal (mildly hypercholesterolemic). For men, these ®gures were seven and four, respectively. One man and three women smoked cigarettes, 19 women used oral contraceptives and one woman was postmenopausal.
Design and diets
The study, which was approved by the Medical Ethics Committee of Maastricht University, had a double-blind, placebo-controlled cross-over design (Figure 1 ). Each subject received three different diets for 4 weeks in one of the six possible treatment orders. There was no washout period between the three different dietary periods. Before the start of the study, the subjects were randomly allocated to one of the six groups. The participants were instructed to maintain their customary lifestyles and home diets throughout the study. During the study, they recorded in diaries any symptoms, visits to physicians, medication used, menstrual phase, alcohol use and any deviation from the protocol. Body weight was recorded weekly.
During the study, the subjects were required to replace at breakfast and at lunch their habitual margarines for an experimental margarine of which, at breakfast 10 g and at lunch 20 g, had to be consumed. Within 1 h after dinner, each participant also had to eat a cake or cookie, which contained 10 g of an experimental shortening. These cakes and cookies were prepared every week by a local bakery especially for this study. To control fat and fatty acid intake as much as possible, each participant also received during each period a shortening without plant stanol esters that had to be used for baking and cooking.
One experimental margarine contained 4.2 ga100 g plant stanols as its fatty acid (low plant stanol ester margarine), and another margarine 12.5 ga100 g (high plant stanol ester margarine). The plant stanol concentration in the experimental shortening was 12.5 ga100 g. Products provided during the control period did not contain any plant stanol esters.
The mixture of vegetable oil and pinewood-derived plant stanols contained approximately 76% sitostanol and 24% campestanol. Sitostanol was prepared from b-sitosterol and stigmasterol, and campestanol from campesterol, both by hydrogenation. Free sitostanol and campestanol were transesteri®ed with rapeseed oil fatty acids, forming fat-soluble sitostanol and campestanol esters. The plant stanol esters were then mixed with the experimental margarines and shortening. The plant stanol esters were added to the experimental margarines at the expense of water and to the experimental shortening at the expense of absorbable fats. All the margarines and shortenings were prepared from low erucic acid rapeseed oil (LEAR) and contained 68% (margarines), 99% (control shortening) or 86% (experimental shortening) absorbable fats. All margarines and the shortening were forti®ed with normal amounts of vitamin A and D. b-Carotene was used as a coloring agent, while vitamin E was present as a natural compound. The margarines and shortenings were produced and provided by the Raisio Group, Raisio, Finland.
At a daily intake of 10 g margarine at breakfast, 20 g margarine at lunch, and 10 g shortening incorporated into the cakes and cookies after dinner, the aimed plant stanol intake during the experimental periods was 2.5 g. The distribution of plant stanol intake over the day, however, was different (Figure 2 ). During the once per day period the 2.5 g of plant stanols were consumed once per day at lunch, while during the three times per day period the plant stanols were provided in amounts proportional to cholesterol intake (Ministeries van Welzijn, Volksgezondheid en Cultuur en van Landbouw, Natuurbeheer en Visserij, 1993). Thus, 0.42 g plant stanols were consumed at breakfast, 0.84 g at lunch and 1.25 g at dinner.
The volunteers had to come at least once a week to the Department to receive a new supply of products. The experimental margarines were given in color-labeled tubs, which contained 75 g margarine (breakfast) or 145 g margarine (lunch). The cookies or cakes were provided in similarly color-labeled bags. The tubs and the bags provided margarine, cakes and cookies for one week. Parts of Figure 1 Experimental design of the study.
Consumption frequency, plant stanols and serum lipids J Plat et al all experimental products that were left over at the end of the week had to be returned and were weighed back to calculate the consumption of the experimental margarines and shortening for that week. The shortening without plant stanol esters was packed in a tub of 200 g, which could be used for more than one week. During the last week of each period, the participants had to ®ll in a food frequency questionnaire about their eating habits of the previous 4 weeks, in order to estimate their energy and nutrient intakes. Details of the food frequency questionnaire have been published before (Plat & Mensink, 2000) . A dietician immediately checked the questionnaires in presence of the subject, for completeness and inconsistencies. Food intake was divided over breakfast, between breakfast and lunch (morning snacks), lunch, afternoon snacks, dinner and evening snacks. Composition of the diets was calculated as described before (Plat & Mensink, 2000) .
Blood sampling
Blood was sampled after an overnight fast and after abstinence from drinking alcohol the preceding day and smoking on the morning before blood sampling. All venipunctures were performed by the same person, at the same location and approximately at the same time of the day. No blood was sampled on Mondays. Blood was sampled once at the beginning of the study (day 1) and twice at the end of each dietary period (weeks 3 and 4, 7 and 8, 11 and 12).
A 10 ml clotting tube was always sampled (CORVAC, integrated serum separator tube, Sherwood Medical Company, St Louis, MO, USA). Serum was obtained by lowspeed centrifugation at 2000 g for 15 min at 4 C, at least 1 h after venipuncture, and then immediately stored in small portions at À80 C. Serum was used for lipids and lipoprotein analysis. At weeks 0, 4, 8 and 12 blood was also sampled using a 10 ml EDTA tube (Sherwood Medical, Monoject). Plasma was prepared from EDTA blood by centrifuging at 2000 g for 30 min at 4 C. Aliquots were snap-frozen and stored directly at À80 C for analysis of antioxidants. Serum and EDTA blood were also used for analysis of parameters for liver and kidney function, Creactive protein concentrations and hematological parameters. These parameters were not affected by the diets (Plat & Mensink, 1999) .
Chemical analysis
All samples from one subject were analyzed in the same analytical run for total and HDL cholesterol and triacylglycerol concentrations as described before (Plat & Mensink, 2000) . The coef®cients of variation within runs were 1.9% for serum total cholesterol 2.0% for HDL cholesterol and 3.4% for triacylglycerol. LDL cholesterol concentrations were calculated using the Friedewald equation (Friedewald et al, 1972) .
Plasma concentrations of tocopherols (a-tocopherol, d-tocopherol, b g-tocopherol), several carotenoids (a-carotene, b-carotene, lycopene, luteinazeaxanthin, b-cryptoxanthin and phyto¯uene) and retinol were determined simultaneously, as described (Hess et al, 1991; Oostenbrug et al, 1997) . Brie¯y, plasma samples were extracted twice with hexane, while retinylacetate was used as internal standard. Antioxidant concentrations were determined by reversed-phase high-pressure liquid chromatography (HPLC). Samples from one subject of weeks 3, 8 and 12 were analyzed in the same analytical run. The mean recovery of retinylacetate was 96.0 + 7.9%.
Statistical analysis
The data were analyzed with the General Linear Models (GLM) procedure of the SAS program (SAS Institute Inc., 1985) . For each subject, lipid and lipoprotein concentrations of weeks 3 and 4, of 7 and 8, and of weeks 11 and 12 were ®rst averaged. The model to examine diet effects included subject, diet, period, carry-over effect and diet6 sex as independent variables. Since the carry-over effect, period and the diet6sex interaction term never reached statistical signi®cance, these terms were subsequently omitted from the model. Thus the ®nal model included subject and diet. When the analysis indicated a signi®cant effect of diet (P`0.05), the Tukey method was used to compare the diets pairwise. All values are presented as their means + standard deviations (s.d.), except in Figure 3 , in which values are presented as means + s.e. Table 1 shows the estimated daily plant sterol and stanol intakes, as derived from the experimental margarines and shortenings. As expected, total intakes of plant stanols during the once per day diet (2468 + 173 mg) and during the three times per day diet (2456 + 121 mg) were signi®-cantly higher than those during the control diet (P`0.001). Total plant stanol (P 0.672) and sitostanol (P 0.578) intake was similar during the once per day period and the three times per day period. The slightly higher campestanol intake of 23 mg or 4%, during the once per day period, compared to the three times per day period, was signi®cant (P`0.001). This difference was due to a slight difference in the sitostanolacampestanol ratio of the plant stanol ester mixtures used for the preparation of the low and the high stanol ester margarines.
Results
Dietary intakes and body weight
The daily energy intake and the proportion of energy from the macronutrients and alcohol, as well as cholesterol and ®ber consumption, were essentially the same during the three periods of the study. Slight, statistically signi®cant, differences existed in the intakes of fatty acids. This was mainly due to the slightly lower absorbable fat content of the stanol ester shortening compared with the control shortening. Consumption frequency, plant stanols and serum lipids J Plat et al During the control period, mean estimated daily margarine intake at breakfast was 10.1 + 0.6 g, and at lunch was 18.8 + 1.8 g, while the estimated shortening incorporated into the cakes and cookies consumed after dinner was 9.6 + 0.8 g. For the once per day period, these values were respectively 10.1 + 0.6, 19.3 + 1.4 and 9.6 + 0.8 g, and for the three times per day period respectively 10.2 + 0.6, 18.8 + 1.7 and 9.6 + 0.6 g. Table 2 shows the estimated plant stanol intakes as derived from the margarines and shortening, as well as the cholesterol intakes as divided over breakfast, lunch and dinner, which were all as anticipated. The cakes or cookies prepared with the experimental shortenings were consumed approximately 22 + 20 min after dinner with no difference between the three periods.
During the different periods of the study, changes in body weight were marginal. At the start of the study mean body weight was 64.5 + 10 kg for women and 75.2 + 9 kg for men. At the end of the control period body weight was 64.7 + 10 kg for women and 75.7 + 9 kg for men and at the end of the once per day diet and the three times per day diet, mean body weights were 64.2 + 10 and 64.5 + 10 kg for women and 75.3 + 9 and 75.7 + 9 kg for men, respectively. These values were not signi®cantly different (P 0.982 for the diet of diet for women and P 0.993 for men). Table 3 shows that plant stanol ester consumption once a day lowered serum total cholesterol concentrations by 0.32 mmolal or 12mgadl compared with the control period, a reduction of 6.3% + 6.2% (P`0.001; 95% con®dence interval (CI), À0.20 to À0.44 mmolal). Consumption of a similar amount of plant stanol esters, distributed Consumption frequency, plant stanols and serum lipids J Plat et al over the day with the three meals, lowered total cholesterol concentrations by 0.33 mmolal or 13 mgadl, a reduction of 6.6% + 7.8% compared with the control period (P`0.001; 95% CI, À0.21 to À0.45 mmolal). The difference of 0.01 mmolal for total cholesterol between the once per day period and the three times per day period was not signi®cant (P 0.808; 95% CI, À0.11 to 0.13 mmolal). Effects of plant stanol esters on serum total cholesterol were mainly caused by effects on serum LDL cholesterol which were, compared with the control period, signi®cantly decreased by 0.29 mmolal or 12 mgadl (À9.4% + 9.1%; P`0.001; 95% CI, À0.19 to À0.39 mmolal) after the once per day period and with 0.31 mmolal or 12mgadl (À10.4% + 11.9%; P`0.001; 95% CI,À0.20 to À0.41 mmolal) after the three times per day period. As for total cholesterol, the difference of 0.02 mmolal for LDL cholesterol concentrations between the once per day period and the three times per day period was not signi®cantly different (P 0.764; 95% CI,À0.09 to 0.11 mmolal). Serum HDL cholesterol and triacylglycerol concentrations were not changed by the diets. Therefore, the total to HDL cholesterol ratios were signi®cantly lower at the end of the once per day period (3.4 + 1.4; P 0.002) and at the end of the three times per day period (3.4 + 1.3; P`0.001), compared to the control diet (3.6 + 1.5).
Serum lipids and lipoproteins
Fat soluble antioxidants
Consumption of plant stanol esters, either once or three times a day, signi®cantly lowered absolute a-tocopherol and b-carotene concentrations (Table 4 ). The reduced lycopene and b-cryptoxanthin concentrations nearly reached signi®cance after the once per day period (P 0.044 and 0.032, respectively), while concentrations of both antioxidants were signi®cantly lower after the three times per day period (both P 0.001). In addition, during the three times per day period also phyto¯uene (P 0.008), and b g tocopherol (P 0.007) concentrations were signi®cantly decreased, and changes in luteinazeaxanthin concentrations nearly reached signi®cance (P 0.023). Retinol concentrations were not affected by plant stanol ester consumption.
Although differences between the once and the three times per day period never reached statistical signi®cance, changes for all antioxidants studied were more pronounced after the three times per day period. Also, changes were larger for the sum of the less polar hydrocarbon carotenoids (ie a-carotene, b-carotene and lycopene) compared with reductions for the sum of the more polar oxygenated carotenoids (ie luteinazeaxanthin and b-cryptoxanthin) and the sum of the tocopherols, which are more polar than the carotenoids.
After standardization of the antioxidant concentrations for LDL cholesterol (Table 5) , none of the antioxidant concentrations was signi®cantly different from the concentrations at the end of the control period. Changes in LDL cholesterol standardized hydrocarbon carotenoids were still slightly negative on the once per day diet (À0.017 + 0.018 mmolammol LDL cholesterol; P 0.307) and À0.032 + 0.016 mmolammol LDL cholesterol (P 0.049) on the three times per day diet. In contrast, after standardization for LDL cholesterol, changes were slightly positive for the oxygenated carotenoids and the tocopherols (Figure 3) .
Discussion
Many studies have demonstrated that plant stanol esters, when consumed three times a day with each meal (Miettinen et al, 1995; Gylling et al, 1997; Plat & Mensink, 2000) or twice a day at lunch and dinner (Weststrate & Meijer, Table 1 . Concentrations are expressed in mmolal, except for phyto¯uene, which is expressed in mV*minaml (ampli®cation 100). *P`0.001 as compared with the control period.
{ P`0.01 as compared with the control period. Table 1 . Concentrations are expressed in mmolammol LDL cholesterol, except for phyto¯uene which is expressed in mV*minanmol LDL cholesterol (ampli®cation 100).
Consumption frequency, plant stanols and serum lipids J Plat et al 1998), lower serum total and LDL cholesterol concentrations. We have now demonstrated that a daily intake of 2.5 g plant stanols as its fatty acid esters, either consumed once per day (at lunch) or divided over three meals (0.4 g at breakfast, 0.8 g at lunch and 1.2 g at dinner), resulted in a similar decrease in serum total and LDL cholesterol. The amount of plant stanols in the latter period was divided over the three meals in such a way that the largest intake was at dinner and the lowest intake at breakfast. This differentiation is largely in correspondence with the distribution of cholesterol intake over the day (Ministeries van Welzijn, Volksgezondheid en Cultuur en van Landbouw, Natuurbeheer en Visserij, 1993; Table 2) . Our ®ndings therefore demonstrate that it is not necessary to consume plant stanol ester products simultaneously with dietary cholesterol or with each meal. This provides variety and may increase compliance for potential consumers. Like in other studies, serum HDL cholesterol and triacylglycerol concentrations were not affected. As a result, the total to HDL cholesterol ratio was signi®cantly lower at the end of both the once per day and the three times per day period, as compared with the control period. The mechanism by which plant stanol esters affect lipoprotein metabolism and lower serum cholesterol concentrations has only partly been elucidated. It is, however, generally assumed that the intestinal absorption of both dietary and biliary cholesterol is reduced in the presence of plant stanols, since the micellar solubility of cholesterol is lowered (Ikeda et al, 1989) . Therefore, it has been suggested that plant sterols, which also lower the micellar solubility of cholesterol, should be consumed at each cholesterol-containing meal to achieve an optimal effect (Mattson et al, 1982) . However, this suggestion is not supported by our ®ndings. We therefore hypothesize that plant stanols, or plant stanol esters, remain in the intestinal lumen or in the enterocytes for a while. Indeed, only 70% of an orally administered single bolus of 14 C labeled sitostanol to male Wistar rats is found in the feces after 24 h (Ikeda & Sugano, 1978) . After 2 and 3 days the cumulative fecal excretions were 90% and 97%, respectively. Thus, when the low absorption of sitostanol into the circulation (Hassan & Rampone, 1979) is neglected, at least 25 ± 30% of the sitostanol is still in the intestinal tract after one day. However, when rats were fed 0.5% cholesterol and 0.5% sitostanol (WaW) for 18 days, the daily fecal excretion of sitostanol showed a recovery of approximately 100% (Sugano et al, 1977) . This implies that in rats, at least within 18 days, a steady state was reached and sitostanol intake equaled sitostanol excretion. This still does not elucidate whether sitostanol remains in the intestinal lumen, and if so, in which part, or in the enterocytes. It also does not answer the question of how long plant stanols are active in the intestine. Studies with caco-2 cells have addressed the question whether micellar 14 C-labeled sitosterol could be taken up in the enterocyte and subsequently be excreted across the basolateral membrane (Field et al, 1997) . To our knowledge no such studies with sitostanol have been published. It appeared that sitosterol was indeed associated with the caco-2 cells. It was, however, not esteri®ed intracellular and not excreted to the basolateral medium. This implies that sitosterol can indeed remain in or can be associated with enterocytes. The functional signi®cance of these ®ndings, however, is unknown. Theoretically sitosterol could remain associated with the enterocytes only temporarily, be released into the lumen after several hours, and consequently affect micellar solubility of intestinal cholesterol at that moment. It can, however, also be speculated that plant sterols or stanols not only affect micellar solubility of cholesterol, but have additional effects on intestinal lipoprotein metabolism as well.
In this study, serum LDL cholesterol concentrations were signi®cantly reduced by 9 ± 10%, when plant stanol esters were consumed. In a previous study, also in a normocholesterolemic and mildly hypercholesterolemic population, serum LDL cholesterol concentrations decreased by 11 ± 13%, when 3.8 or 4.0 g plant stanols as its fatty acid esters were consumed (Plat & Mensink, 2000) . As already discussed (Mensink & Plat, 1998; Wester, 1999) , hardly any additional bene®t is obtained when daily intake of plant stanols exceeds 2.2 g.
Although total fat consumption during the three diet periods was similar, the fatty acid compositions of the diets were not entirely comparable. This was due to the slightly lower absorbable fat content of the stanol ester shortening compared with the control shortening. However, the marginal differences in the dietary fatty acid compositions were too small to have a major impact on serum lipoproteins. The LDL-cholesterol-lowering effect of the once per day period might have been overestimated by 0.02 mmolal compared with the control period, while the LDL-cholesterol-lowering effect of the three times per day diet might have been underestimated by 0.01 and 0.04 mmolal, when compared with the control period and the once per day period, respectively (Mensink & Katan, 1992) .
Consumption of 2.5 g plant stanols three times a day signi®cantly lowered most of the carotenoid and tocopherol isomers studied. In contrast, consumption of a similar amount of plant stanols once day at lunch only resulted in reduced absolute a-tocopherol and b-carotene concentrations. In addition, all antioxidants studied showed slightly lower concentrations at the end of the three times per day period compared with the concentrations at the end of the once per day period (Tables 4 and 5 ). These absolute reductions can be explained largely by a reduced number of LDL particles in the circulation, which are major carriers of the fat-soluble antioxidants. Therefore, the differences were no longer signi®cant after standardization for LDL choles- Figure 3 Percentage changes of LDL cholesterol standardized plasma hydrocarbon carotenoid, oxygenated carotenoid and tocopherol concentrations (mmolammol LDL cholesterol) at the end of the once per day period and the three times per day period, both compared with the concentrations at the end of the control period (means+ s.e.). Hydrocarbon carotenoids were calculated as the sum of b-carotene, a-carotene and lycopene, oxygenated carotenoids as the sum of luteinazeaxanthin and b-cryptoxanthin, and tocopherols as the sum of a-tocopherol, b g-tocopherol and d-tocopherol.
Consumption frequency, plant stanols and serum lipids J Plat et al terol. Furthermore, we have shown that, in particular, the most lipophylic hydrocarbon carotenoid concentrations (ie a-carotene, b-carotene and lycopene) were lowered by plant stanol ester consumption. The mechanism and the biological signi®cance of these effects, however, remain to be elucidated. From our results we conclude that a daily consumption of 2.5 g plant stanols as fatty acid esters either at lunch or divided over the three meals does not affect its serum LDLcholesterol-lowering ef®cacy. This implies that it is not necessary to consume plant stanol esters simultaneously with dietary cholesterol or with each meal. We therefore hypothesize that plant stanols, or plant stanol esters, remain in the intestinal lumen, or possibly in or associated with the enterocytes. It can also be speculated that plant stanols not only affect micellar solubility of cholesterol, but have other intestinal effects on lipoprotein metabolism as well. Therefore, further research will be necessary to elucidate the mechanism by which plant stanols lower LDL cholesterol.
